Literature DB >> 24780512

International Alzheimer's Disease Research Portfolio (IADRP) aims to capture global Alzheimer's disease research funding.

Charlene Liggins1, Heather M Snyder2, Nina Silverberg3, Suzana Petanceska3, Lorenzo M Refolo3, Laurie Ryan3, Maria C Carrillo4.   

Abstract

Alzheimer's disease (AD) is a recognized international public health crisis. There is an urgent need for public and private funding agencies around the world to coordinate funding strategies and leverage existing resources to enhance and expand support of AD research. To capture and compare their existing investments in AD research and research-related resources, major funding organizations are starting to utilize the Common Alzheimer's Disease Research Ontology (CADRO) to categorize their funding information. This information is captured in the International Alzheimer's Disease Research Portfolio (IADRP) for further analysis. As of January, 2014, over fifteen organizations from the US, Canada, Europe and Australia have contributed their information. The goal of the IADRP project is to enable funding organizations to assess the changing landscape of AD research and coordinate strategies, leverage resources, and avoid duplication of effort.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Alzheimer's disease; Biomedical research; Ontology; Research classification

Mesh:

Year:  2014        PMID: 24780512     DOI: 10.1016/j.jalz.2013.12.013

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  9 in total

1.  Introducing Alzheimer's & Dementia: Translational Research & Clinical Interventions, an open access journal of the Alzheimer's Association.

Authors:  Lon S Schneider
Journal:  Alzheimers Dement (N Y)       Date:  2015-07-01

2.  Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer's disease neuroimaging initiative.

Authors:  Xiaohui Yao; Jingwen Yan; Michael Ginda; Katy Börner; Andrew J Saykin; Li Shen
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

3.  A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025.

Authors:  James Pickett; Cathy Bird; Clive Ballard; Sube Banerjee; Carol Brayne; Katherine Cowan; Linda Clare; Adelina Comas-Herrera; Lynne Corner; Stephanie Daley; Martin Knapp; Louise Lafortune; Gill Livingston; Jill Manthorpe; Natalie Marchant; Jo Moriarty; Louise Robinson; Clare van Lynden; Gill Windle; Bob Woods; Katherine Gray; Clare Walton
Journal:  Int J Geriatr Psychiatry       Date:  2018-02-22       Impact factor: 3.485

4.  Improving the Gene Ontology Resource to Facilitate More Informative Analysis and Interpretation of Alzheimer's Disease Data.

Authors:  Barbara Kramarz; Paola Roncaglia; Birgit H M Meldal; Rachael P Huntley; Maria J Martin; Sandra Orchard; Helen Parkinson; David Brough; Rina Bandopadhyay; Nigel M Hooper; Ruth C Lovering
Journal:  Genes (Basel)       Date:  2018-11-29       Impact factor: 4.096

Review 5.  A roadmap to develop dementia research capacity and capability in Pakistan: A model for low- and middle-income countries.

Authors:  Iracema Leroi; Nasim Chaudhry; Anna Daniel; Ross Dunne; Saima Eman; Nicolas Farina; Sana-E-Zehra Haidry; Nusrat Husain; Hussain Jafri; Salman Karim; Tayyeba Kiran; Murad Khan; Quratulain Khan; Shakil Jehangir Malik; Rakhshi Memon; Mowadat Hussain Rana; Ambily Sathish; Saima Sheikh; Asad Tamizudin; Sehrish Tofique; Zainab Zadeh
Journal:  Alzheimers Dement (N Y)       Date:  2019-12-28

Review 6.  Vascular contributions to cognitive impairment and dementia: Research consortia that focus on etiology and treatable targets to lessen the burden of dementia worldwide.

Authors:  Jordan T Gladman; Roderick A Corriveau; Stephanie Debette; Martin Dichgans; Steven M Greenberg; Perminder S Sachdev; Joanna M Wardlaw; Geert Jan Biessels
Journal:  Alzheimers Dement (N Y)       Date:  2019-11-19

7.  The costs of developing treatments for Alzheimer's disease: A retrospective exploration.

Authors:  Jeffrey L Cummings; Dana P Goldman; Nicholas R Simmons-Stern; Eric Ponton
Journal:  Alzheimers Dement       Date:  2021-09-28       Impact factor: 16.655

8.  MicroRNA-98 reduces amyloid β-protein production and improves oxidative stress and mitochondrial dysfunction through the Notch signaling pathway via HEY2 in Alzheimer's disease mice.

Authors:  Fang-Zhou Chen; Ying Zhao; Hui-Zhao Chen
Journal:  Int J Mol Med       Date:  2018-10-24       Impact factor: 4.101

9.  Drug Development for Psychotropic, Cognitive-Enhancing, and Disease-Modifying Treatments for Alzheimer's Disease.

Authors:  Jeffrey Cummings
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2020-10-28       Impact factor: 2.198

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.